Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2009-01-13 17:40 |
POURSUITE D'UNE DYNAMIQUE COMMERCIALE OFFENSIVE
|
French | 69.4 KB | ||
| 2009-01-12 17:45 |
BILAN SEMESTRIEL CONTRAT DE LIQUIDITE
|
French | 84.0 KB | ||
| 2009-01-08 17:45 |
PUBLICATION ACTION ET DROITS DE VOTE
|
French | 7.5 KB | ||
| 2008-12-17 17:40 |
VIVALIS AND KAKETSUKEN SIGN TWO COMMERCIAL LICENSE AGREEMENTS
|
English | 113.8 KB | ||
| 2008-12-17 17:40 |
VIVALIS ET KAKETSUKEN SIGNENT DEUX LICENCES COMMERCIALES
|
French | 115.4 KB | ||
| 2008-12-10 17:40 |
VIVALIS OBTIENT LA DELIVRANCE DE BREVETS MAJEURS
|
French | 79.0 KB | ||
| 2008-12-10 17:40 |
VIVALIS SECURES IMPORTANT PATENTS
|
English | 92.0 KB | ||
| 2008-12-05 17:45 |
DECLARATION DROIT DE VOTE
|
French | 7.4 KB | ||
| 2008-11-05 17:40 |
Déclaration actions et droit de vote octobre 2008
|
French | 7.2 KB | ||
| 2008-11-04 17:40 |
VIVALIS A LA CONFERENCE INVESTISSEURS RODMAN & RENSHAW
|
French | 139.0 KB | ||
| 2008-11-04 17:40 |
VIVALIS AT THE RODMAN & RENSHAW HEALTHCARE CONFERENCE
|
English | 85.1 KB | ||
| 2008-10-28 17:40 |
VIVALIS: Accelerating commercial growth in 2008 Q3
|
English | 157.7 KB | ||
| 2008-10-28 17:40 |
VIVALIS : Accélération de dynamique commerciale au 3e T 2008
|
French | 153.8 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
